HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Reliant Launches Cosmeceutical Line To Complement Fraxel Laser Treatment

This article was originally published in The Rose Sheet

Executive Summary

Reliant Technologies is introducing a home-use cosmeceutical skin-care line to complement its Fraxel skin rejuvenation laser treatment, the firm announced Sept. 8 at the Medical Spa and Resort Expo and Conference in New York

You may also be interested in...



Reliant Links With Philips To Develop Laser Skin-Care Device For Home Use

Reliant Technologies Inc., developer of Fraxel laser systems, has partnered with electronics giant Philips to develop laser skin-rejuvenation technology for use at home, taking a cue from some of the industry's biggest players that are making moves toward the aesthetic devices market

Reliant Links With Philips To Develop Laser Skin-Care Device For Home Use

Reliant Technologies Inc., developer of Fraxel laser systems, has partnered with electronics giant Philips to develop laser skin-rejuvenation technology for use at home, taking a cue from some of the industry's biggest players that are making moves toward the aesthetic devices market

Today’s Beauty Market: From Sampling Campaigns To Surgery Complements

Success in today's beauty market may come easier to firms that embrace innovative sampling, address problems above and below the neck, take up a new attitude about sun care and launch personal-care products that complement surgical procedures, according to industry veteran Alisa Marie Beyer

Related Content

UsernamePublicRestriction

Register

RS014974

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel